ESTIMATION OF TOLERANCE OF A DOMESTIC NON-STEROID ANTI-INFLAMMATORY DRUG IN THE POSTOPERATIVE PERIOD OF EXTRACTION OF CATARACTS
DOI:
https://doi.org/10.11603/bmbr.2706-6290.2021.2.12343Keywords:
cataract, non-steroidal anti-inflammatory drug, tolerance of non-steroidal anti-inflammatory drug, side effects of non-steroidal anti-inflammatory drugAbstract
Summary. The article discusses the efficacy and tolerability of a non-steroidal anti-inflammatory domestic drug after cataract extraction, the severity of side effects of a non-steroidal anti-inflammatory drug.
The aim of the study – optimization of methods of postoperative treatment of cataracts using the domestic non-steroidal anti-inflammatory Diclofenac drug, 0.1 % eye drops, produced by JV “Jurabek Laboratories” LLC.
Materials and Methods. The study included patients who were at inpatient treatment at the Clinic No. 2 of the Tashkent Medical Academy. The study group included 60 people: 21 men and 39 women, the age of patients was 18–73 years. In two groups, we compared the efficacy and tolerability of domestic and foreign NSAIDs after cataract extraction.
Results. The effectiveness of the complex treatment is confirmed by the reduction in the duration of relief of the main symptoms of inflammation in patients of both groups. Both drugs did not cause side effects and were well tolerated by patients. Tolerability of the treatment in the group receiving domestic NSAIDs was 93.4 %, in the group receiving foreign NSAIDs – 95.7 %.
Conclusions. According to the results of our studies, it was proved that therapy after cataract extraction with the use of a domestic-made NSAID is not inferior in efficiency and tolerability to a foreign-made drug and can be used in the postoperative period of cataract.
References
Akhuja M, Sharma SK, Majumdar DK. Penetration of diclofenac through the cornea from oil droplets in vitro. Yakugaku Zasshi. 2007;127: 1739-45.
Van der Beil P, van Eyck AD, Seyfarth HI, Viljoen I, Jooste M. Percutaneous penetration of diclofenac and topical piroxicam. J Appl Res. 2003;3: 505-11.
Ioshin IE, Tolchinskaya AI, Kalinnikov YuYu, Ozderbaeva AA. Prevention of macular edema in cataract phacoemulsification. Russian Ophthalmological Journal. 2014;2: 21-6.
Koroleva IA, Egorov EA. Heading: Ophthalmology. RMJ "Clinical Ophthalmology". 2018;4: 194-8 DOI: 10.21689 / 2311-7729-2018-18-4-194-198.
Kim SJ, Flach AJ, Jampol LM. Non-steroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol. 2010;55: 108-33.
Kessel L, Tendal B, Jørgensen KJ. Prevention of macular inflammation and edema after cataract with steroid and non-steroidal anti-inflammatory eye drops; systematic review. Ophthalmology. 2014;121: 1915-24.
Mishima S, Tanishima T, Masuda K. Pathophysiology and pharmacology of intraocular surgery. Aust NZJ Ophthalmol. 1985;13: 147-58.
Flach AJ. Topical non-steroidal anti-inflammatory drugs in ophthalmology. Int Ophthalmol Clin. 2002;42: 1-11.
Hashemi H, Seidian MA, Mohammadpur M. Small pupil and cataract surgery. Curr Opin Ophthalmol. 2015;26: 3-9.
Shalnus R. Actual non-steroidal anti-inflammatory therapy in ophthalmology. Ophthalmologica. 2003;217: 89-98.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Bulletin of Medical and Biological Research

This work is licensed under a Creative Commons Attribution 4.0 International License.